Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (ARB) and neutral endopeptidase (NEP) inhibitor

Details for Australian Patent Application No. 2008324878 (hide)

Owner Novartis AG

Inventors Royce, Alan Edward; Hu, Jiahui; Zannou, Erika Aina; Al-Fayoumi, Suliman; Ruegger, Colleen; Kumaraperumal, Natrajan

Agent Davies Collison Cave

Pub. Number AU-A-2008324878

PCT Pub. Number WO2009/061713

Priority 60/985,668 06.11.07 US

Filing date 4 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/216 (2006.01)

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/061713 Priority application(s): WO2009/061713

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324893-Bone mill including a base and a mill head separate from the base, the mill head including a moveable catch tray

2008324872-High temperature stable anatase titanium dioxide